Clinical Trial Update: Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adverse events and changes in disease activity with oral cariprazine in adults with schizophrenia has been terminated and results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: AbbVie | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED | Results posted: 2025-10-20